Shanda Asset Management Holdings LTD Aprea Therapeutics, Inc. Transaction History

Shanda Asset Management Holdings LTD

  • $1.77 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$21.66 - $38.86 $256,952 - $460,996
-11,863 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$25.47 - $39.69 $302,150 - $470,842
11,863 New
11,863 $460,000

Others Institutions Holding APRE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Aprea Therapeutics, Inc.

APRE Quotes by TradingView
  • Ticker APRE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Description
  • Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...
More about APRE
Track This Portfolio

Track Shanda Asset Management Holdings LTD Portfolio

Follow Shanda Asset Management Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shanda Asset Management Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Shanda Asset Management Holdings LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email